Compare AVXL & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | MITT |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.2M | 244.9M |
| IPO Year | 2013 | N/A |
| Metric | AVXL | MITT |
|---|---|---|
| Price | $2.59 | $8.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $22.00 | $9.25 |
| AVG Volume (30 Days) | ★ 1.4M | 167.1K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.96% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.48 |
| Revenue Next Year | N/A | $5.06 |
| P/E Ratio | ★ N/A | $9.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.41 | $6.86 |
| 52 Week High | $13.99 | $9.27 |
| Indicator | AVXL | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 58.16 |
| Support Level | $2.41 | $7.50 |
| Resistance Level | $3.07 | $8.28 |
| Average True Range (ATR) | 0.18 | 0.21 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 35.00 | 59.75 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.